NEO · NASDAQ · Medical - Diagnostics & Research

NeoGenomics

Runs cancer diagnostic laboratories serving community oncologists, pathologists, and pharmaceutical trial sponsors.

$18.20
After-hours close+0.15 (+0.86%)
At close$18.05(−3.19%)
DateEstimateReportedSurprise
Oct 2026$0.06
Jul 2026$0.03$0.05+49.0%
Apr 2026$0.01$0.01+73.0%
Feb 2026$0.04$0.06+50.0%
Oct 2025$0.02$0.03+50.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 2025
Apr 2025
Feb 2025
Nov 2024
Jul 2024
Apr 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
Apr 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Feb 2021
Oct 2020
Jul 2020
Apr 2020
Feb 2020
Oct 2019
Jul 2019
Apr 2019
Feb 2019
Oct 2018
Jul 2018
May 2018
Feb 2018
Oct 2017
Jul 2017
Apr 2017
Feb 2017
Oct 2016
Jul 2016
Apr 2016
Mar 2016
Oct 2015
Jul 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 27, 2026$0.06$205.9M
Jul 28, 2026$0.03$0.05+49.0%$196.9M$201.7M+2.4%
Apr 28, 2026$0.01$0.01+73.0%$184.5M$186.7M+1.2%
Feb 17, 2026$0.04$0.06+50.0%$188.5M$190.2M+0.9%
Oct 28, 2025$0.02$0.03+50.0%$188.2M$187.8M−0.2%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 29, 2025
Apr 29, 2025
Feb 18, 2025
Nov 5, 2024
Jul 29, 2024
Apr 30, 2024
Feb 20, 2024
Nov 6, 2023
Aug 8, 2023
May 8, 2023
Feb 23, 2023
Nov 8, 2022
Aug 9, 2022
Apr 27, 2022
Feb 23, 2022
Nov 4, 2021
Aug 6, 2021
May 5, 2021
Feb 24, 2021
Oct 27, 2020
Jul 28, 2020
Apr 28, 2020
Feb 27, 2020
Oct 29, 2019
Jul 30, 2019
Apr 30, 2019
Feb 19, 2019
Oct 30, 2018
Jul 24, 2018
May 1, 2018
Feb 21, 2018
Oct 25, 2017
Jul 25, 2017
Apr 26, 2017
Feb 22, 2017
Oct 26, 2016
Jul 26, 2016
Apr 27, 2016
Mar 1, 2016
Oct 29, 2015
Jul 23, 2015